Apurba wins project to optimize cost, efficacy, adherence and utilization of specialty drugs using machine learning
Added on 15th January 2017
SUNNYVALE, Calif., Jan 15th, 2017 – Apurba wins a big data analytics contract to optimize the cost, efficacy, adherence, and utilization of specialty drugs.
The big-data analytics platform will leverage machine-learning algorithms to identify the most clinically effective specialty medications at an optimal cost for individual patients, which can then be extended to execute cost-benefit analysis on the behalf of entire medical institutions. This platform is aimed at ushering in a new era of precision medicine, providing actionable intelligence that enables healthcare providers the ability to prescribe exactly the right drug, for the right patient, all at an optimized value.
Apurba Technologies Inc. is a Sunnyvale, CA, based software development company that creates enterprise big data solutions for natural language processing, visualization and analytics.
